BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zou J, Pei X, Xing D, Wu X, Chen S. LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3. J Cell Mol Med 2021;25:9826-36. [PMID: 34541823 DOI: 10.1111/jcmm.16930] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Barwal TS, Sharma U, Rana MK, Bazala S, Singh I, Murmu M, Kapoor HS, Thakur S, Jain M, Jain A. A diagnostic and prognostic value of blood-based circulating long non-coding RNAs in Thyroid, Pancreatic and Ovarian Cancer. Crit Rev Oncol Hematol 2022;:103598. [PMID: 35033662 DOI: 10.1016/j.critrevonc.2022.103598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Niu Y, Wang G, Li Y, Guo W, Guo Y, Dong Z. LncRNA FOXP4-AS1 Promotes the Progression of Esophageal Squamous Cell Carcinoma by Interacting With MLL2/H3K4me3 to Upregulate FOXP4. Front Oncol 2021;11:773864. [PMID: 34970490 DOI: 10.3389/fonc.2021.773864] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Zou J, Pei X, Xing D, Wu X, Chen S. LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3. J Cell Mol Med 2021;25:9826-36. [PMID: 34541823 DOI: 10.1111/jcmm.16930] [Cited by in F6Publishing: 3] [Reference Citation Analysis]